ZymoGenetics establishes global collaboration with Bayer for development and commercialization of recombinant human thrombin.: An article from: BIOTECH Patent News
Book Details
Author(s)
Gale Reference Team
Publisher
Thomson Gale
ISBN / ASIN
B000W7YVP6
ISBN-13
978B000W7YVP5
Availability
Available for download now
Marketplace
United States 🇺🇸
Ratings & Reviews
No reviews yet — be the first!
No reviews yet.
Description
This digital document is an article from BIOTECH Patent News, published by Thomson Gale on June 1, 2007. The length of the article is 822 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: ZymoGenetics establishes global collaboration with Bayer for development and commercialization of recombinant human thrombin.
Author: Gale Reference Team
Publication:BIOTECH Patent News (Newsletter)
Date: June 1, 2007
Publisher: Thomson Gale
Volume: 21 Issue: 6
Distributed by Thomson Gale
Citation Details
Title: ZymoGenetics establishes global collaboration with Bayer for development and commercialization of recombinant human thrombin.
Author: Gale Reference Team
Publication:BIOTECH Patent News (Newsletter)
Date: June 1, 2007
Publisher: Thomson Gale
Volume: 21 Issue: 6
Distributed by Thomson Gale
